Sammy Saab, Cristina Wiese, Ayman B. Ibrahim, Lisette Peralta, Francisco Durazo, Steven Han, Hasan Yersiz, Douglas G. Farmer, R. Mark Ghobrial, Leonard I. Goldstein, Myron J. Tong, Ronald W. Busuttil – 30 August 2007 – The purposes of liver transplantation (LT) include the extension of survival, improvement in quality of life, and the return of the recipient as a contributing member of society. Employment is one measure of the ability to return to society. The aim of this study is to determine the factors affecting employment/subemployment after LT.

James D. Perkins – 30 August 2007

Dorry L. Segev, Geoffrey C. Nguyen, Jayme E. Locke, Christopher E. Simpkins, Robert A. Montgomery, Warren R. Maley, Paul J. Thuluvath – 30 August 2007 – Several treatment options exist for the management of Budd‐Chiari syndrome (BCS), yet the relative role and timing of liver transplantation (LT) remain poorly defined. Small case series published to date have not been able to delineate the impact of comorbidities and thromboembolic complications of BCS on survival after LT.

Frank V. Schiødt, Kristian Bangert, A. Obaid Shakil, Timothy McCashland, Natalie Murray, J. Eileen Hay, William M. Lee – 30 August 2007 – Serum concentrations of the actin scavenger Gc‐globulin may provide prognostic information in acute liver failure (ALF). The fraction of Gc‐globulin not bound to actin is postulated to represent a better marker than total Gc‐globulin but has been difficult to measure.

Stephan Singer, Volker Ehemann, Antje Brauckhoff, Martina Keith, Sebastian Vreden, Peter Schirmacher, Kai Breuhahn – 24 August 2007 – The microtubule (MT)‐destabilizing protein stathmin/Op18 has previously been described to be negatively regulated by p53 and to be highly expressed in several tumor entities. However, little is known about its expression profile, functional or therapeutic relevance, and regulation in human hepatocarcinogenesis.

Tatjana Stojakovic, Csilla Putz‐Bankuti, Günter Fauler, Hubert Scharnagl, Martin Wagner, Vanessa Stadlbauer, Gerald Gurakuqi, Rudolf E. Stauber, Winfried März, Michael Trauner – 24 August 2007 – Statin therapy may target both hypercholesterolemia and cholestasis in primary biliary cirrhosis (PBC). However, little is known about the efficacy and safety of statins in PBC.

Paulette Bioulac‐Sage, Sandra Rebouissou, Cristel Thomas, Jean‐Frédéric Blanc, Jean Saric, Antonio Sa Cunha, Anne Rullier, Gaëlle Cubel, Gabrielle Couchy, Sandrine Imbeaud, Charles Balabaud, Jessica Zucman‐Rossi – 24 August 2007 – Hepatocellular adenomas (HCA) with activated β‐catenin present a high risk of malignant transformation. To permit robust routine diagnosis to allow for HCA subtype classification, we searched new useful markers.

Yongyan Chen, Haiming Wei, Rui Sun, Zhongjun Dong, Jian Zhang, Zhigang Tian – 24 August 2007 – The innate immunopathogenesis responsible for the susceptibility to hepatocyte injury in chronic hepatitis B surface antigen carriers is not well defined. In this study, hepatitis B virus (HBV) transgenic mice (named HBs‐Tg) were oversensitive to liver injury after immunologic [polyinosinic:polycytidylic acid or concanavalin A (ConA)] or chemical (CCl4) triggering.

Yu‐Chi Chou, Mong‐Liang Chen, Cheng‐Po Hu, Ya‐Ling Chen, Chin‐Liew Chong, Yue‐Lin Tsai, Tzu‐Ling Liu, King‐Song Jeng, Chungming Chang – 24 August 2007 – Transforming growth factor–beta1 (TGF‐β1) is a pleiotropic cytokine with pivotal roles in the regulation of cellular functions and immune responses. In this study, we found that TGF‐β1 was able to effectively suppress hepatitis B virus (HBV) replication. In the presence of TGF‐β1, the level of viral replicative intermediates was dramatically decreased, both in actively dividing cells and in confluent cells.

Gloria Lena Vega, Manisha Chandalia, Lidia S. Szczepaniak, Scott M. Grundy – 24 August 2007 – Nonalcoholic hepatic steatosis associates with a clustering of metabolic risk factors and steatohepatitis. One risk factor for hepatic steatosis is obesity, but other factors likely play a role. We examined metabolic concomitants of hepatic steatosis in nonobese and obese men and women. Sixty‐one obese women and 35 obese men were studied; both those with and without hepatic steatosis were compared against each other and against nonobese controls (17 women and 32 men) without hepatic steatosis.